Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury

Scandinavian Journal of Gastroenterology

Volumn 46, Issue 3, 2011, Pages 281-286

  Shiotani, Akiko ^a   Honda, Keisuke ^a   Murao, Takahisa ^a   Ishii, Manabu ^a   Fujita, Minoru ^a   Matsumoto, Hiroshi ^a   Tarumi, Ken Ichi ^a   Kamada, Tomoari ^a   Sakakibara, Takashi ^b   Haruma, Ken ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b THE SAKAKIBARA HEART INSTITUTE OF OKAYAMA   (Japan)

Author keywords

Aspirin; obscure gastrointestinal bleeding; thienopyridine; video capsule endoscopy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN;

AGED; ARTICLE; CAPSULE ENDOSCOPY; CONTROLLED STUDY; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE INJURY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBSCURE GASTROINTESTINAL BLEEDING; PRIORITY JOURNAL; VIDEO CAPSULE ENDOSCOPY;

AGED; AGED, 80 AND OVER; ASPIRIN; CAPSULE ENDOSCOPY; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; PYRIDINES; RETROSPECTIVE STUDIES; TICLOPIDINE; ULCER; WARFARIN;

EID: 79751488508     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.533381     Document Type: Article

References (19)

1. Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol 2008;43:581-8.
2. Leung WK, Bjarnason I, Wong VW, Sung JJ, Chan FK. Small bowel enteropathy associated with chronic low-dose aspirin therapy. Lancet 2007;369:614. (Pubitemid 46241446)
3. Endo H, Hosono K, Inamori M, Kato S, Nozaki Y, Yoneda K, et al. Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endos-copy in healthy volunteers. Digestion 2009;79:44-51.
4. Endo H, Hosono K, Inamori M, Nozaki Y, Yoneda K, Fujita K, et al. Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol 2009;44:544-9.
5. Smecuol E, Pinto Sanchez MI, Suarez A, Argonz JE, Sugai E, Vazquez H, et al. Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009;7:524-9.
6. Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008;6:1279-82.
7. Collaborative overview of randomised trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ 1994;308:159-68.
8. Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101: 1206-18. (Pubitemid 30146625)
9. Collaborative meta-analysis of randomised trials of antiplate-let therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Col-laboration. BMJ 2002;324:71-86.
10. Cooke GE, Goldschmidt-Clermont PJ. The safety and effi-cacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease. Expert Opin Drug Saf 2006;5:815-26. (Pubitemid 44669496)
11. Dai X, Makaryus AN, Makaryus JN, Jauhar R. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Rev Cardiovasc Med 2009;10:14-24.
12. Tan VP, Yan BP, Kiernan TJ, Ajani AE. Risk and manage-ment of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention. Cardiovasc Revasc Med 2009;10: 36-44.
13. Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, et al. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol 2010; 45:292-8.
14. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55-9. (Pubitemid 40092944)
15. Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, et al. Use of single and combined antithrom-botic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. Bmj 2006; 333:726.
16. Shiotani A, Sakakibara T, Yamanaka Y, Imamura H, Tarumi K, Manabe N, et al. Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol 2009;44:126-31.
17. Hoftiezer JW, Silvoso GR, Burks M, Ivey KJ. Comparison of the effects of regular and enteric-coated aspirin on gastro-duodenal mucosa of man. Lancet 1980;2:609-12. (Pubitemid 10056648)
18. Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994;343:85-6. (Pubitemid 24019350)
19. van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996;72 Suppl 2: S39-48; discussion S49-51. (Pubitemid 126733521)